Developing Effective Local Treatments
for Urinary Tract  Diseases

Our Mission

Trigone Pharma is dedicated to developing safe and effective local treatments for urinary tract diseases.


Our first product in development addresses the unmet need for efficient and localized treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS). This chronic bladder condition causes recurring bouts of pain and pressure in the bladder and pelvic area, often accompanied by an urgent and frequent need to urinate.  


Trigone Pharma's product is designed to provide longer exposure of the urinary tract tissue to medications. It enables localized therapy to be a highly effective treatment option by increasing the sustained release of drugs and dwell time in the bladder for safe therapeutic effect and improved patient compliance. Our product integrates well-established regulatory compliant components that present effective, safe, easy-to-handle, and user-friendly treatment administration at 1-4 weeks intervals. 


Our Pipeline




Over Active Bladder


Renal Colic


Bladder Cancer

© 2020 by Trigone Pharma

15 HaTidhar Street, Raanana, Israel


Tel: +972-9-7403336